ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,827.94
-1.43%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Alnylam Pharmaceuticals Inc (ALNY)

  7. Alnylam Pharmaceuticals Inc (ALNY) 뉴스

ALNY Alnylam Pharmaceuticals Inc

143.31
-0.40 (-0.28%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Alnylam Pharmaceuticals Inc ALNY 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.40 -0.28% 143.31 06:30:00
개장가 저가 고가 종가 전일 종가
144.08 143.00 146.065 143.31 143.71
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
18/04/202421:00BWAlnylam to Webcast Conference Call Discussing First Quarter..
07/04/202421:00BWAlnylam Presents Positive Results from the KARDIA-2 Phase 2..
20/03/202421:00BWAlnylam to Webcast Investor Event to Discuss Results from..
13/03/202420:30BWAlnylam Launches Hereditary ATTR (hATTR) Amyloidosis..
06/03/202420:50BWAlnylam meldet positive KARDIA-2 Topline-Studienergebnisse,..
06/03/202407:39BWAlnylam annonce des résultats positifs de l’étude KARDIA-2..
06/03/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202421:30BWAlnylam Reports Positive KARDIA-2 Topline Study Results..
05/03/202406:33EDGAR2Form 8-K - Current report
01/03/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:00EDGAR2Form 144 - Report of proposed sale of securities
27/02/202422:30BWAlnylam to Webcast Presentations at Upcoming March Investor..
21/02/202406:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202406:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/02/202422:10EDGAR2Form 8-K - Current report
15/02/202422:00BWAlnylam Pharmaceuticals Reports Fourth Quarter and Full Year..
10/02/202408:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/01/202422:00BWAlnylam to Webcast Conference Call Discussing Fourth Quarter..
20/01/202406:31EDGAR2Form 8-K - Current report
09/01/202422:05BWAlnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year..
08/01/202421:00EDGAR2Form 8-K - Current report
08/01/202408:00BWAlnylam Announces Preliminary* Fourth Quarter and Full Year..
02/01/202421:30BWAlnylam to Webcast Presentation at 42nd Annual J.P. Morgan..
30/12/202306:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202306:03EDGAR2Form 144 - Report of proposed sale of securities
13/12/202321:30BWAlnylam Highlights Significant Progress with Platform..
12/12/202306:07EDGAR2Form 144 - Report of proposed sale of securities
06/12/202322:00BWAlnylam to Webcast Virtual R&D Day
30/11/202322:00BWAlnylam Ranks #1 on Boston Globe’s Top Places to Work List..
13/11/202302:08BWAlnylam présente des résultats positifs de l'étude KARDIA-1..
12/11/202306:00BWAlnylam Presents Positive Results from the KARDIA-1 Phase 2..
07/11/202322:00BWAlnylam to Webcast Presentations at Upcoming November..
02/11/202321:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:10EDGAR2Form 8-K - Current report
02/11/202321:00BWAlnylam Pharmaceuticals Reports Third Quarter 2023 Financial..
27/10/202303:00BWAlnylam Recognized by Science Magazine as Top Employer for..
26/10/202306:19BWAlnylam Announces Publication of Results from APOLLO-B Phase..
26/10/202300:05BWAlnylam Reports Additional Positive Interim Phase 1 Results..
19/10/202321:00BWAlnylam to Webcast Conference Call Discussing Third Quarter..
10/10/202320:30EDGAR2Form 8-K - Current report
10/10/202320:02IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations

최근 히스토리

NASDAQ
ALNY
Alnylam Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유